Acquired Immunodeficiency Syndrome: all 3,037 studies
Page 22 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.
- CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment RegimesCompletedNCT00966160Phase 3
- Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CTCompletedNCT00958815
- Raltegravir Switch for Toxicity or Adverse EventsCompletedNCT00958100Phase 2
- Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell CountsWithdrawnNCT00951795
- Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)Status unknownNCT00951743Phase 2
- Computerized HIV/Sexually Transmitted Disease (STD) Prevention ProgramCompletedNCT00947947Phase 2
- Effect of Antacids on the Pharmacokinetics of RaltegravirCompletedNCT00944307Phase 1
- Integration of Family Planning and HIV Services in TanzaniaCompletedNCT00941876Not applicable
- A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, AfricaCompletedNCT00931346Phase 1/2
- Integration of HIV Care and Treatment Into Antenatal Care in Migori District, KenyaCompletedNCT00931216Not applicable
- HIV Viral Load Monitoring in Resource-Poor SettingsCompletedNCT00929604Not applicable
- Natural History Study of HIV Acquired in Infancy or ChildhoodCompletedNCT00924365
- DDI Study of Etravirine and GSK1265744CompletedNCT00920296Phase 1
- Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe DrugsCompletedNCT00920088Phase 1
- An Expanded Safety Study of Dapivirine Gel 4789 in AfricaCompletedNCT00917904Phase 1/2
- An Expanded Safety Study of Dapivirine Gel 4759 in AfricaCompletedNCT00917891Phase 1/2
- Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in KenyaCompletedNCT00914225
- Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV TreatmentCompletedNCT00909129Not applicable
- Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIVCompletedNCT00908284Not applicable
- Empowerment Intervention for Young Women - Phase ICompletedNCT00891358Not applicable
- Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in TanzaniaCompletedNCT00885287Phase 4
- Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS PatientsStatus unknownNCT00872417Phase 4
- Anatomic and Visual Function Assessments on Asymptomatic HIV-positive PatientsCompletedNCT00871078
- Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study)CompletedNCT00868257
- Predictors of Neuro-cognitive Decline and Survival in HIV-infected SubjectsCompletedNCT00864292
- High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCTTerminatedNCT00858793Phase 1/2
- Effect of Diet-induced Weight Loss on HIV-associated Metabolic SyndromeCompletedNCT00857298Not applicable
- Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal TissueCompletedNCT00855088Phase 1
- A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult VolunteersCompletedNCT00851383Phase 1
- Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected MenCompletedNCT00846599
- Transitions: Linkages From Jail To CommunityCompletedNCT00841711Not applicable
- Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug MonitoringStatus unknownNCT00836212Phase 4
- Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in KenyaCompletedNCT00830622Not applicable
- Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)CompletedNCT00829114Phase 4
- VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy VolunteerCompletedNCT00828789Phase 1
- Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIVCompletedNCT00826345Not applicable
- Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese VolunteersCompletedNCT00821535Phase 1
- Effective Aids Treatment and Support in the Free State (FEATS)Status unknownNCT00821366Phase 3
- Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?TerminatedNCT00817713Not applicable
- Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years OldCompletedNCT00814762Phase 1
- Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.CompletedNCT00812318Phase 1
- Impact of Different Contraceptives on the Immune System of HIV Infected Women in ZambiaCompletedNCT00807625Phase 2
- Cerebral Toxoplasmosis and AIDSCompletedNCT00803621
- Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With HemophiliaStatus unknownNCT00797381
- Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)CompletedNCT00796770Phase 1
- The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in UgandaStatus unknownNCT00790959Not applicable
- Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected AdultsCompletedNCT00790881Phase 4
- Healthy Teen Girls: HIV Risk ReductionCompletedNCT00787696Phase 1/2
- Directly Observed Therapy for Community-Released HIV+ PrisonersCompletedNCT00786396Not applicable
- Influenza Vaccination in Immunocompromized PatientsCompletedNCT00783380Phase 4
- Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsWithdrawnNCT00782301Phase 4
- Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1TerminatedNCT00781287Phase 4
- Case Management Alternatives for African American Women at High Risk for HIVCompletedNCT00780260Phase 3
- Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal TissueCompletedNCT00775294Phase 1
- GSK1349572 Drug Interaction Study With Protease InhibitorsCompletedNCT00774735Phase 1
- A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected WomenCompletedNCT00774683
- Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, JerusalemStatus unknownNCT00758212Not applicable
- Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART TherapyTerminatedNCT00757250Phase 1
- Attitudes and Beliefs and the Steps of HIV CareCompletedNCT00749840
- Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV TherapyCompletedNCT00747539
- TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.CompletedNCT00744887Phase 1
- TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.CompletedNCT00740389Phase 1
- TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.CompletedNCT00739622Phase 1
- Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) TreatmentTerminatedNCT00737724Not applicable
- TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.CompletedNCT00736905Phase 1
- Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase InhibitorsCompletedNCT00730223Phase 1
- Combination of an Investigational Cannabinoid and Methadone for HIV-associated NeuropathyWithdrawnNCT00723918Phase 2
- GSK706769/KALETRA Drug-drug Interaction StudyCompletedNCT00723775Phase 1
- Family Centered Advanced Care Planning for Adolescents With HIV/AIDS and Their FamiliesCompletedNCT00723476Not applicable
- Cognitive Behavioral Stress Management for HIV+ Drug AbusersCompletedNCT00722644Phase 1
- Intervention for (Those) Recently Informed of Seropositive Status (IRISS)CompletedNCT00720733Not applicable
- Maraviroc Compassionate UseWithdrawnNCT00719823Phase 3
- Cerebrospinal Fluid (CSF) Raltegravir SubstudyCompletedNCT00718029
- Social-Psychological Intervention to Improve Adherence to HAARTStatus unknownNCT00716040Not applicable
- GSK706769 Repeat Dose StudyCompletedNCT00711386Phase 1
- Durability of Nevirapine-Based Antiretroviral RegimenCompletedNCT00703898Phase 4
- The Human Immunodeficiency Virus and Osteopathic Manipulation Evaluation StudyCompletedNCT00703248Not applicable
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisCompletedNCT00698334Phase 3
- Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug CombinationsCompletedNCT00697892Phase 1
- Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infectionStatus unknownNCT00692809
- Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole SusceptibilityTerminatedNCT00692783
- Pilot Trial of a Synbiotic in HIV+ PatientsCompletedNCT00688311Not applicable
- Enhancing Communication and HIV OutcomesCompletedNCT00675610Phase 3
- Impact of Peer Health Workers and Mobile Phones on HIV CareCompletedNCT00675389Not applicable
- Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, UgandaStatus unknownNCT00674921Phase 4
- Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIVCompletedNCT00672191Phase 2
- Safety and Efficacy of Kaletra in ARV Therapy Experienced PatientsCompletedNCT00648999Phase 4
- HIV Counseling and Testing and Linkage to Care in UgandaCompletedNCT00648232Not applicable
- Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)CompletedNCT00643903Not applicable
- HIV Prevention With the Mentally IllCompletedNCT00643305Phase 2
- Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingCompletedNCT00642499Phase 2
- Impact of Antiretroviral Therapy on Cardiac BiomarkersCompletedNCT00641888
- Reactogenicity and Immunogenicity of Vaginal CNgp140TerminatedNCT00637962Phase 1
- Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)WithdrawnNCT00636935Phase 4
- Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)CompletedNCT00632073Phase 1
- Yoga for the Management of HIV-Metabolic SyndromesCompletedNCT00627380Phase 4
- Acupuncture for Nausea in HIVCompletedNCT00624793Phase 2
- Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy AdultsTerminatedNCT00623753Phase 1
- Cognitive Stimulation Program in AIDSCompletedNCT00619567Phase 1
- Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation CohortCompletedNCT00618176Phase 4